The differential effects of ApoE isoforms on AD risk are given at least in part by the ability to affect Aβ aggregation and clearance in the brain, effects on synaptic plasticity, cell signaling, lipid transport and metabolism, and neuroinflammation [78]. The gene discussed is APOE; the disease is Alzheimer disease.